Literature DB >> 23486519

Inhibition of TGF-β1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis.

Nan Shen1, Hongli Lin, Taihua Wu, Dapeng Wang, Weidong Wang, Hua Xie, Jianing Zhang, Zhe Feng.   

Abstract

The profibrotic cytokine transforming growth factor-β1 (TGF-β1) causes renal fibrosis by binding to receptors at the cell surface; however, it is not clear which of the TGF-β superfamily receptors correlates with renal fibrosis. To resolve this, we quantified TGF-β superfamily receptor expression in the kidneys of rats with unilateral ureteral obstruction using a real-time PCR gene array. Expression of activin receptor-like kinase (ALK)-5, ALK7, and TGF-β receptor II (TGF-βRII) mRNA increased significantly, while ALK6 mRNA expression was significantly decreased in the obstructed rat kidney. Core fucosylation is essential for the proper function of both TGF-βRII and ALK5 in cultured human renal proximal tubular epithelial cells in vitro. Therefore, we targeted posttranslational core fucosylation, regulated by α-1,6 fucosyltransferase (FUT8), by adenoviral-mediated knockdown of FUT8 mRNA in vivo and measured TGF-βRII and ALK5 expression and the progression of renal fibrosis. Despite long-term obstruction injury, inhibition of TGF-βRII and ALK5 of core fucosylation ameliorated the progression of renal fibrosis, an effect independent of TGF-βRII and ALK5 expression. Thus, the regulation of TGF-β1-receptor core fucosylation may provide a novel potential therapeutic strategy for treating renal fibrosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23486519     DOI: 10.1038/ki.2013.82

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  22 in total

1.  Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway.

Authors:  Yifan Zhang; Shengzhou Shan; Jing Wang; Xinyu Cheng; Bo Yi; Jia Zhou; Qingfeng Li
Journal:  Mol Cell Biochem       Date:  2016-01-04       Impact factor: 3.396

2.  siRNA-targeting transforming growth factor-β type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue.

Authors:  Yi-Wen Wang; Nien-Hsien Liou; Juin-Hong Cherng; Shu-Jen Chang; Kuo-Hsing Ma; Earl Fu; Jiang-Chuan Liu; Niann-Tzyy Dai
Journal:  J Invest Dermatol       Date:  2014-02-13       Impact factor: 8.551

3.  Bone marrow mesenchymal stem cell-derived exosomal miR-34c-5p ameliorates RIF by inhibiting the core fucosylation of multiple proteins.

Authors:  Xuemei Hu; Nan Shen; Anqi Liu; Weidong Wang; Lihua Zhang; Zhigang Sui; Qingzhu Tang; Xiangning Du; Ning Yang; Wantao Ying; Biaojie Qin; Zhitong Li; Lin Li; Nan Wang; Hongli Lin
Journal:  Mol Ther       Date:  2021-10-19       Impact factor: 11.454

4.  Glycyrrhizic Acid Inhibits Core Fucosylation Modification Modulated EMT and Attenuates Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Lili Gao; Nan Wang; Yu Jiang; Jinying Hu; Baojie Ma; Taihua Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-06       Impact factor: 2.650

5.  Inhibiting post-translational core fucosylation protects against albumin-induced proximal tubular epithelial cell injury.

Authors:  Dapeng Wang; Ming Fang; Nan Shen; Longkai Li; Weidong Wang; Lingyu Wang; Hongli Lin
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

6.  MicroRNA-196a/b Mitigate Renal Fibrosis by Targeting TGF-β Receptor 2.

Authors:  Jiao Meng; Limin Li; Yue Zhao; Zhen Zhou; Mingchao Zhang; Donghai Li; Chen-Yu Zhang; Ke Zen; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2016-03-03       Impact factor: 10.121

7.  Spatial N-glycomics of the human aortic valve in development and pediatric endstage congenital aortic valve stenosis.

Authors:  Peggi M Angel; Richard R Drake; Yeonhee Park; Cassandra L Clift; Connor West; Savanna Berkhiser; Gary Hardiman; Anand S Mehta; David P Bichell; Yan Ru Su
Journal:  J Mol Cell Cardiol       Date:  2021-01-29       Impact factor: 5.000

8.  Blocking core fucosylation of epidermal growth factor (EGF) receptor prevents peritoneal fibrosis progression.

Authors:  Changqing Yu; Ning Yang; Weidong Wang; Xiangning Du; Qingzhu Tang; Hongli Lin; Longkai Li
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

Review 9.  TGF-β/Smad signaling in renal fibrosis.

Authors:  Xiao-Ming Meng; Patrick Ming-Kuen Tang; Jun Li; Hui Yao Lan
Journal:  Front Physiol       Date:  2015-03-19       Impact factor: 4.566

Review 10.  Glycosylation of Immune Receptors in Cancer.

Authors:  Ruoxuan Sun; Alyssa Min Jung Kim; Seung-Oe Lim
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.